Deep Track Capital, LP Intellia Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 4,210,784 shares of NTLA stock, worth $94.2 Million. This represents 3.83% of its overall portfolio holdings.
Number of Shares
4,210,784
Previous 2,250,000
87.15%
Holding current value
$94.2 Million
Previous $68.6 Million
68.86%
% of portfolio
3.83%
Previous 2.61%
Shares
7 transactions
Others Institutions Holding NTLA
# of Institutions
313Shares Held
89.3MCall Options Held
686KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$246 Million2.16% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$204 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$204 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$103 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.16MShares$93.1 Million0.02% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.7B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...